Navigation Links
Biophysical Reviews makes debut in 2009
Date:1/14/2009

The International Union for Pure and Applied Biophysics (IUPAB) and Springer will launch the journal Biophysical Reviews in spring 2009. Biophysical Reviews is the new official journal of the IUPAB, the leading international biophysics organization consisting of 52 national societies with approximately 15,000 members. The entire IUPAB Council will form the editorial board of the new journal in order to demonstrate the close affiliation between the Springer journal and the IUPAB.

Biophysical Reviews will publish short and critical reviews from key scientists active in the field. The quarterly journal will cover the entire field of biophysics, generally defined as the science of describing biological phenomena and resolving their underlying principles using the concepts and techniques of physics. This includes, but is not limited to, such areas as bioinformatics, biophysical methods and instrumentation, medical biophysics, biosystems and cell biophysics. The editor-in-chief, Professor Jean Garnier of the Institut National de la Recherche Agronomique (INRA) - Unit Mathmatique Informatique et Gnome (France) will work closely with the expert international editorial board.

Dr. Sabine Schwarz, Senior Editor for Life Sciences at Springer, said, "We are excited about the IUPAB's decision to cooperate with Springer. The new journal will provide top-level reviews in biophysics, which will of course all be peer-reviewed. This aspect, combined with the high-caliber editorial board and the IUPAB's previous publishing experience, provides the perfect preconditions for a successful journal."

Professor Kuniaki Nagayama, President of the International Union for Pure and Applied Biophysics, said, "The IUPAB requires a useful and broadly informative official journal, and our old journal did not serve our purposes well. Now, in cooperation with Springer, we are starting the new official journal, Biophysical Reviews. I am pl
'/>"/>

Contact: Renate Bayaz
renate.bayaz@springer.com
49-622-148-78531
Springer
Source:Eurekalert

Page: 1 2

Related biology news :

1. Media highlights in the November issues of Biophysical Journal
2. Roger Kornberg to present lecture at the Joint Biophysical Society/IUPAB Meeting
3. Media highlights in the Dec. 15 issue of Biophysical Journal
4. Biophysical Society announces 2008 International Travel Awards
5. Biophysical Society announces winners of 2008 Student Travel Awards
6. Biophysical Society announces winners of 2008 Minority Travel Awards
7. Biophysical Society to host discussions on the teaching of evolution and on the energy crisis
8. Biophysical Society announces new and notable symposium speakers
9. Media highlights in the January issues of Biophysical Journal
10. Media highlights in the March 1 issue of Biophysical Journal
11. Cell Press announces new partnership with the Biophysical Society
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... 2014) Scientists at The New York Stem ... closer to creating a viable cell replacement therapy ... , For the first time, NYSCF scientists ... skin samples of patients with primary progressive multiple ... to induce these stem cells into becoming oligodendrocytes, ...
(Date:7/24/2014)... York, NY - July 24, 2014 -- Keryx Biopharmaceuticals, ... from the long-term, randomized, active control Phase 3 study ... iron-based phosphate binder, for the treatment of hyperphosphatemia in ... PERFECTED study (PhosphatE binding and iRon delivery with FErric ... Journal of the American Society of Nephrology ...
(Date:7/24/2014)... YORK, NY (July 24, 2014) Scientists at ... Institute are one step closer to creating a ... a patient,s own cells. , For the ... (iPS) cells lines from skin samples of patients ... developed an accelerated protocol to induce these stem ...
Breaking Biology News(10 mins):NYSCF scientists one step closer to cell therapy for multiple sclerosis patients 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 4NYSCF scientists 1 step closer to cell therapy for multiple sclerosis patients 2
... Hopkins scientists seems to have discovered an almost-too-easy way to ... potent versions. Their finding, reported this week in Nature, could ... but also other body tissues. What the researchers ... neural stem cells the sort that might be used ...
... The giant panda is not at an evolutionary dead end ... new research involving scientists from Cardiff University. Previous ... requirements and slow reproductive rates have led to a lack ... extinction. Now a study by Professor Michael Bruford ...
... August 23, 2007 On August 16, the Food and ... sold under the brand name Coumadin. The new label suggests ... be safer for patients with variations in two genes, CYP2C9 ... testing, which may be a useful tool in determining appropriate ...
Cached Biology News:When is a stem cell not really a stem cell? 2American College of Medical Genetics responds to new FDA labeling decision for warfarin 2
(Date:7/24/2014)... DUBLIN , July 24, 2014 ... the "Global Cell Culture Market 2014-2018" report ... Cell culture is the in vitro ... such as research, cell studies, and biopharmaceutical production. Cell ... vaccine production. Cell culture instruments and cell culture consumables ...
(Date:7/24/2014)... Your cell phone may stay charged ... storage capacity. , New research indicates that lithium-ion ... at Lawrence Livermore National Laboratory and ... components will perform as electrodes. , The growing ... for higher-performance batteries. Several key characteristics of lithium-ion ...
(Date:7/24/2014)...  CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical ... for the prevention and treatment of cardiorenal and ... July 18, 2014 from the NYSE MKT LLC ... plan to regain compliance with continued listing standards ... is continuing the Company,s listing and has granted ...
(Date:7/24/2014)... 2014 2014 Deep Research Report ... a professional and in-depth research report on Potassium ... basic information, including its definition, classification, application, ... research covers the international market analysis, including China’s ... covering macroeconomic environment & economic situation analysis, the ...
Breaking Biology Technology:Global Cell Culture Market 2014-2018: Key Vendors are Becton, Dickinson and Co, EMD, GE Healthcare, Lonza Group, Sigma Aldrich and Thermo Fisher Scientific 2Getting More Life out of Lithium-ion Batteries 2CorMedix, Inc. Granted Extension of NYSE-MKT Listing 2CorMedix, Inc. Granted Extension of NYSE-MKT Listing 3Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 2Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 3Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 4
... , , ROCKVILLE, Md., ... has announced that 263 regulatory professionals achieved Regulatory Affairs ... RAC credential is administered by RAPS and is the ... product sector. , , (Logo: ...
... BEIJING, Sept. 4 /PRNewswire-Asia/ -- ... provider of biopharmaceutical products in China, announced today that,the ... Republic,of China has issued the initial order to Sinovac ... to the initial order, Sinovac is,required to complete the ...
... September 4 Karolinska Development (publ),today announced that one ... clinical study of its candidate drug, tafoxiparin, a,new drug ... promising results of the Phase II trial bring the ... strategy. , Dilafor,s candidate drug, ...
Cached Biology Technology:263 Regulatory Professionals Achieve RAC Certification 2263 Regulatory Professionals Achieve RAC Certification 3Sinovac Obtains Initial Order of H1N1 Vaccine from Chinese Central Government 2Sinovac Obtains Initial Order of H1N1 Vaccine from Chinese Central Government 3Karolinska Development Portfolio Company Completes Successful Phase II Clinical Trial 2Karolinska Development Portfolio Company Completes Successful Phase II Clinical Trial 3
Request Info...
supplied with 10x reaction buffer...
... from yeast/leuconostoc overproducer ATP: ... EC 2.7.1.1/1.1.1.49. One unit of ... of D-glucose in 1 min ... One unit of G6P-DH will ...
Request Info...
Biology Products: